“Not only was the jury unconvinced by the SEC's showing with regard to misstatements, the jury outright rejected the SEC's fraudulent scheme charge; the jury al...
Read moreLemelson Capital Chief Comments on Unprecedented 9-year SEC Fight over Ligand Pharmaceuticals (NASDAQ: LGND) Jerricho, New York, December 12, 2023 — Rev. Emmanu...
Read moreLemelson Capital focuses on value and special situations, but it is one of the few that builds ethics into its decisions." - Paul Springer, May 18, 2018, The De...
Read moreAmvona Store: August 1999 - April 2010 - Initial capital: $300 - 1999-2003: One employee - (mostly) in a dorm room - 1999-2005: Growth completely self-financed...
Read more
